AAAAAA
Results:
1-17
|
Results: 17
Authors:
POPESCU RA
LOHRI A
DEKANT E
THIEDE C
REUTER J
HERRMANN R
ROCHLITZ CF
Citation: Ra. Popescu et al., BCL-2 EXPRESSION IS RECIPROCAL TO P53 AND C-MYC EXPRESSION IN METASTATIC HUMAN COLORECTAL-CANCER, European journal of cancer, 34(8), 1998, pp. 1268-1273
Authors:
POPESCU RA
LOHRI A
DEKANT E
THIEDE C
HERRMANN R
ROCHLITZ CF
Citation: Ra. Popescu et al., BCL-2 EXPRESSION IS REDUCED AND RECIPROCAL TO P53 AND C-MYC EXPRESSION IN ADVANCED HUMAN COLORECTAL-CANCER, European journal of cancer, 33, 1997, pp. 735-735
Authors:
ROCHLITZ CF
LOHRI A
SASSEROTH G
VANHILLE B
REUTER J
TICHELLI A
BACCHI M
FOPP M
FEY MF
HERRMANN R
Citation: Cf. Rochlitz et al., MTS1 EXPRESSION AND PROGNOSIS IN ACUTE MYELOID-LEUKEMIA, Annals of hematology, 75(4), 1997, pp. 141-144
Authors:
LOHRI A
VANHILLE B
BACCHI M
FOPP M
JONCOURT F
REUTER J
CERNY T
FEY MF
HERRMANN R
Citation: A. Lohri et al., 5 PUTATIVE DRUG-RESISTANCE PARAMETERS (MDR1 P-GLYCOPROTEIN, MDR-ASSOCIATED PROTEIN, GLUTATHIONE-S-TRANSFERASE, BCL-2 AND TOPOISOMERASE II-ALPHA) IN 57 NEWLY-DIAGNOSED ACUTE MYELOID LEUKEMIAS/, European journal of haematology, 59(4), 1997, pp. 206-215
Authors:
GLICKSMAN AS
WANEBO HJ
SLOTMAN G
LIU L
LANDMANN C
CLARK J
ZHU TC
LOHRI A
PROBST R
Citation: As. Glicksman et al., CONCURRENT PLATINUM-BASED CHEMOTHERAPY AND HYPERFRACTIONATED RADIOTHERAPY WITH LATE INTENSIFICATION IN ADVANCED HEAD AND NECK-CANCER, International journal of radiation oncology, biology, physics, 39(3), 1997, pp. 721-729
Authors:
ZUEGER O
BOLLIGER CT
QUADRI F
LOHRI A
SOLER M
IZBICKI G
PERRUCHOUD AP
Citation: O. Zueger et al., CONSERVATIVE MANAGEMENT OF A BRONCHO-ESOPHAGEAL FISTULA IN A PATIENT WITH NON-HODGKINS-LYMPHOMA, Respiration, 64(5), 1997, pp. 388-391
Authors:
LOHRI A
REUTER J
GUDAT F
HERRMANN R
Citation: A. Lohri et al., TOPOISOMERASE II-ALPHA MESSENGER-RNA AND TUMOR-CELL PROLIFERATION IN NON-HODGKINS-LYMPHOMA, Journal of Clinical Pathology, 50(1), 1997, pp. 22-26
Authors:
LOHRI A
VANHILLE B
REUTER J
TICHELLI A
HERRMANN R
Citation: A. Lohri et al., MESSENGER-RNA EXPRESSION, MEASURED BY QUANTITATIVE REVERSE-TRANSCRIPTASE POLYMERASE-CHAIN-REACTION, OF 5 PUTATIVE DRUG-RESISTANCE PARAMETERS, IN NORMAL AND LEUKEMIC PERIPHERAL-BLOOD AND BONE-MARROW, Acta haematologica, 98(1), 1997, pp. 1-7
Authors:
VANHILLE B
LOHRI A
REUTER J
HERRMANN R
Citation: B. Vanhille et al., ASSESSMENT OF DRUG-INDUCED DYSREGULATIONS AMONG 7 RESISTANCE-ASSOCIATED GENES IN HUMAN TUMOR-CELL LINES, Anticancer research, 16(6B), 1996, pp. 3531-3536
Authors:
LOHRI A
LEYVRAZ S
CERNY T
HESS U
HONEGGER HP
GREINER R
CASTIGLIONE M
HERRMANN R
LOFFLER M
HASENCLEVER D
DIEHL V
Citation: A. Lohri et al., PARTICIPATION IN MULTICENTER STUDIES AS QUALITY-CONTROL IN THERAPY OFHODGKINS-DISEASE - AN INTERIM-REPORT, Schweizerische medizinische Wochenschrift, 125(6), 1995, pp. 217-224
Authors:
VANHILLE B
LOHRI A
REUTER J
HERRMANN R
Citation: B. Vanhille et al., NONRADIOACTIVE QUANTIFICATION OF MDR1 MESSENGER-RNA BY POLYMERASE CHAIN-REACTION AMPLIFICATION COUPLED WITH HPLC, Clinical chemistry, 41(8), 1995, pp. 1087-1093
Authors:
ORTH HB
HURWITZ N
LOHRI A
WEBER W
HERRMANN R
Citation: Hb. Orth et al., GAMMA-HEAVY-CHAIN PRODUCTION AS AN EPIPHE NOMENON OF NON-HODGKIN-LYMPHOMA, Deutsche Medizinische Wochenschrift, 119(37), 1994, pp. 1235-1238
Authors:
LOHRI A
CONNORS JM
Citation: A. Lohri et Jm. Connors, IDENTIFICATION OF RISK-FACTORS IN PATIENTS TREATED FOR FIRST RELAPSE OF HODGKINS-DISEASE, Leukemia & lymphoma, 15(3-4), 1994, pp. 189-200
Authors:
LOHRI A
CONNORS JM
Citation: A. Lohri et Jm. Connors, IDENTIFICATION OF RISK-FACTORS IN PATIENTS TREATED FOR FIRST RELAPSE OF HODGKINS-DISEASE, Leukemia & lymphoma, 15(3-4), 1994, pp. 189-200
Authors:
BETTICHER DC
FEY MF
VONROHR A
TOBLER A
JENZER H
GRATWOHL A
LOHRI A
PUGIN P
HESS U
PAGANI O
ZULIAN G
CERNY T
Citation: Dc. Betticher et al., HIGH-INCIDENCE OF INFECTIONS AFTER 2-CHLORODEOXYADENOSINE (2-CDA) THERAPY IN PATIENTS WITH MALIGNANT-LYMPHOMAS AND CHRONIC AND ACUTE LEUKEMIAS, Annals of oncology, 5(1), 1994, pp. 57-64
Authors:
LOHRI A
HERRMANN R
Citation: A. Lohri et R. Herrmann, TESTS TO DETECT DRUG-RESISTANCE IN MALIGNANT-TUMORS - SHOULD THEY GUIDE THE CLINICIAN CHOICE OF TREATMENT, Onkologie, 16(3), 1993, pp. 147-148
Authors:
LOHRI A
HERRMANN R
Citation: A. Lohri et R. Herrmann, ONCOLOGY 1992 - CONTACTS BETWEEN MEDICAL ONCOLOGY AND OPHTHALMOLOGY -WHATS NEW IN ONCOLOGY, Klinische Monatsblatter fur Augenheilkunde, 202(5), 1993, pp. 361-363
Risultati:
1-17
|